Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-23-021050
Filing Date
2023-07-28
Accepted
2023-07-28 16:55:19
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A vtgn20230728_defa14a.htm DEFA14A 8674
2 card01.jpg GRAPHIC 189847
3 card02.jpg GRAPHIC 174381
  Complete submission text file 0001437749-23-021050.txt   511664
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-37761 | Film No.: 231123835
SIC: 2834 Pharmaceutical Preparations